Biomedica is a pharmaceutical company specialized in the commercialization of rare disease products for patients in underserved emerging markets. You can expand your presence with up to 730 million additional people by working with Biomedica.
- We have the capabilities to assist you in expanding your presence in over 25 emerging markets, creating value for your company and addressing unmet patient needs, all while effectively managing risks and ensuring a competitive and fast financial return.
- We provide strategic guidance and recommendations for the most effective market access pathways for both non-registered and registered products to operate efficiently in accordance with regulations and providing expert-based solutions.
- Your product could launch as early as Day 2 after FDA or EMA approval
- If you are in Clinical 2/3 trials for rare/ultra rare disease assets, we can assist you with suitable patient search around in the markets we serve.
Looking forward to discuss your commercializations strategy: firstname.lastname@example.org